CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$28.26
-4.01% today
Updated 2026-04-29
Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.5M
Catalyst Pharmaceuticals Inc (CPRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
36.40%
Operating margin
40.50%
ROE
25.50%
ROA
16.50%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-2.73M | — | — | — |
| 2007 | — | $-4.14M | — | — | — |
| 2008 | — | $-10.56M | — | — | — |
| 2009 | — | $-7.24M | — | — | — |
| 2010 | $488958.00 | $-4.01M | 100.00% | -823.01% | -819.36% |
| 2011 | $0.00 | $-6.39M | — | — | — |
| 2012 | $0.00 | $-4.08M | — | — | — |
| 2013 | $0.00 | $-12.15M | — | — | — |
| 2014 | $0.00 | $-15.51M | — | — | — |
| 2015 | $0.00 | $-20.23M | — | — | — |
| 2016 | $0.00 | $-18.07M | — | — | — |
| 2017 | $0.00 | $-18.41M | — | — | — |
| 2018 | $500000.00 | $-34.00M | 100.00% | -7,059.03% | -6,800.70% |
| 2019 | $102.31M | $31.88M | 85.57% | 31.11% | 31.16% |
| 2020 | $119.07M | $74.98M | 85.69% | 34.69% | 62.97% |
| 2021 | $140.83M | $39.48M | 84.46% | 37.20% | 28.03% |
| 2022 | $214.20M | $83.08M | 83.94% | 47.54% | 38.79% |
| 2023 | $398.20M | $71.41M | 86.95% | 21.80% | 17.93% |
| 2024 | $491.73M | $163.89M | 86.00% | 39.68% | 33.33% |
| 2025 | $588.99M | $214.33M | 85.19% | 43.77% | 36.39% |